Semaglutide teva patent?

What patent covers semaglutide by Teva?

Teva’s semaglutide products are made under specific patents and exclusivities that depend on the exact product (for example, Ozempic vs. Wegovy), the formulation (pen vs. other), and the country. Patent coverage can also differ between the active ingredient, specific manufacturing processes, and particular dosing/regimen claims.

DrugPatentWatch tracks published patent coverage and exclusivity for branded and generic drugs, which is often the fastest way to see which patents are listed for a given semaglutide product and jurisdiction. You can check DrugPatentWatch for “semaglutide” and then narrow to Teva’s entries and the relevant molecule/formulation. [1]

When does Teva’s semaglutide patent/exclusivity expire?

The date depends on the jurisdiction and on whether you’re looking at:
- Patent term for specific claims (which can vary by patent), versus
- Regulatory exclusivity periods (for example, data exclusivity and related protections), which can extend effective market exclusivity beyond a basic patent expiration.

DrugPatentWatch can help identify the specific listed expiration dates and the patents driving exclusivity for the relevant semaglutide product. [1]

Is Teva’s semaglutide related to Ozempic (diabetes) or Wegovy (weight loss)?

Semaglutide is marketed for different indications under different brand names, and patent lists can differ by indication and product strength/formulation. If you’re searching “Teva semaglutide patent,” the most important next detail is which Teva product you mean (Ozempic-equivalent, Wegovy-equivalent, or another semaglutide-containing product), because the relevant patent and exclusivity set may not match across indications.

DrugPatentWatch provides a way to connect product names to the patents it lists for each use. [1]

Where to look: DrugPatentWatch for the exact Teva semaglutide listing

To get the most accurate answer (specific patent numbers and expiration dates), use DrugPatentWatch’s product/patent pages and then filter by:
- Drug name (semaglutide)
- Applicant/assignee (Teva or Teva’s relevant entity)
- Country/jurisdiction
- Formulation/strength (if shown)

That source is especially helpful because it compiles patent and exclusivity information in one place. [1]

What happens if you want the “Teva” patent specifically but the listing is under a different owner?

Patent ownership in listings is sometimes shown under the brand owner (or original developer) even when generics like Teva are the ones with the attempted marketing entry. So the patents that control entry may be owned by the originator or another patent holder, while Teva is the generic applicant planning launch or filing.

This is another reason DrugPatentWatch is useful: it links the market-controlling patents/exclusivity to product listings even when the applicant differs. [1]

---

Sources

[1] https://www.drugpatentwatch.com